NovoNorm
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for NovoNorm, covering 2006-10-13 to 2017-09-28. Get the full timeline:
Most recent: EMA Authorised: NovoNorm (repaglinide) — Novo Nordisk A/S
5 regulatory and trial events tracked for NovoNorm, covering 2006-10-13 to 2017-09-28. Get the full timeline:
Most recent: EMA Authorised: NovoNorm (repaglinide) — Novo Nordisk A/S